Hypertrophic cardiomyopathy (HCM) is a common genetic disorder that affects people regardless of gender, ethnicity, age or geographic location.
HCM is known by many names and it is important to understand that it is, for the most part, one disease. Oftentimes, those with hypertrophic obstructive cardiomyopathy(HOCM, oHCM), apical hypertrophic cardiomyopathy, or asymmetric septal hypertrophic cardiomyopathy think this is a completely different disease. When in reality it is all hypertrophic cardiomyopathy with varied physical presentations. Put differently, the words "obstructive," "apical," or "asymmetric septal" are just descriptions of the current state of the disease.
This website will expand your knowledge of hypertrophic cardiomyopathy as well as issues important to our community by providing clinically reviewed information, support options and member services.
The HCMA is the preeminent organization improving the lives of those with hypertrophic cardiomyopathy, HCM, preventing untimely deaths and advancing global understanding. Founded in 1996 we are committed to providing support, education, advocacy and advancing research, understanding and care to those with HCM.
Should you have questions at any point while reviewing this website, please reach out the the HCMA office at: 973-983-7429 or email us at firstname.lastname@example.org and we will respond as soon as possible.
Each day during February (Heart Month), the HCMA features stories of HCM patients and their unique journeys. The HCMA has changed many lives by being a beacon of light in the darkness. We offer these stories in the hope someone struggling understands that they are not alone but part of an HCM community strengthened by the HCMA.
CALENDAR OF EVENTS
Signing up for our virtual events can be confusing.
If you are having trouble please check out our step-by-step guide for registration.
The HCMA is available for media support to discuss current events, HCM in entertainment, new treatments, or life with HCM. If you have a need about hypertrophic cardiomyopathy please reach out to our media relations team at: